Monitoring of the Effect of Chemotherapy in a Mixed Glioma by C-11-methionine PET

KG Herholz; L Kracht; W D. Heiss

Monitoring of the Effect of Chemotherapy in a Mixed Glioma by C-11-methionine PET

KG Herholz, L Kracht, W D. Heiss

Research output: Contribution to journal › Article › peer-review

Abstract

Neurologische Universitatsklinik, Max-Planck-Institut fur Neurologische Forschung, Gleueler Str 50, 50931 Koln, Germany. [email protected] effect of chemotherapy with procarbazine, CCNU, and vincristine in an anaplastic oligoastrocytoma was monitored by repeated positron emission tomography (PET) with C-11-methionine (C-11-MET). Chemotherapy caused a continuous decline of active tumor volume at a rate of approximately 2.4% per day, resulting in complete remission that persisted until the end of follow-up at 3 years. Thus, the authors conclude that C-11-MET PET may be useful for monitoring chemotherapy in gliomas and deserves further study.PMID: 12889176 [PubMed - indexed for MEDLINE]

Original language	English
Journal	Journal of Neuroimaging
Volume	13(3)
Publication status	Published - 2003

Cite this

@article{c3bc6ef585a44a939f96ea11a7c388b1,

title = "Monitoring of the Effect of Chemotherapy in a Mixed Glioma by C-11-methionine PET",

abstract = "Neurologische Universitatsklinik, Max-Planck-Institut fur Neurologische Forschung, Gleueler Str 50, 50931 Koln, Germany. [email protected] effect of chemotherapy with procarbazine, CCNU, and vincristine in an anaplastic oligoastrocytoma was monitored by repeated positron emission tomography (PET) with C-11-methionine (C-11-MET). Chemotherapy caused a continuous decline of active tumor volume at a rate of approximately 2.4% per day, resulting in complete remission that persisted until the end of follow-up at 3 years. Thus, the authors conclude that C-11-MET PET may be useful for monitoring chemotherapy in gliomas and deserves further study.PMID: 12889176 [PubMed - indexed for MEDLINE]",

author = "KG Herholz and L Kracht and Heiss, {W D.}",

year = "2003",

language = "English",

volume = "13(3)",

journal = "Journal of Neuroimaging",

issn = "1552-6569",

publisher = "John Wiley & Sons Ltd",

}

TY - JOUR

T1 - Monitoring of the Effect of Chemotherapy in a Mixed Glioma by C-11-methionine PET

AU - Herholz, KG

AU - Kracht, L

AU - Heiss, W D.

PY - 2003

Y1 - 2003

N2 - Neurologische Universitatsklinik, Max-Planck-Institut fur Neurologische Forschung, Gleueler Str 50, 50931 Koln, Germany. [email protected] effect of chemotherapy with procarbazine, CCNU, and vincristine in an anaplastic oligoastrocytoma was monitored by repeated positron emission tomography (PET) with C-11-methionine (C-11-MET). Chemotherapy caused a continuous decline of active tumor volume at a rate of approximately 2.4% per day, resulting in complete remission that persisted until the end of follow-up at 3 years. Thus, the authors conclude that C-11-MET PET may be useful for monitoring chemotherapy in gliomas and deserves further study.PMID: 12889176 [PubMed - indexed for MEDLINE]

AB - Neurologische Universitatsklinik, Max-Planck-Institut fur Neurologische Forschung, Gleueler Str 50, 50931 Koln, Germany. [email protected] effect of chemotherapy with procarbazine, CCNU, and vincristine in an anaplastic oligoastrocytoma was monitored by repeated positron emission tomography (PET) with C-11-methionine (C-11-MET). Chemotherapy caused a continuous decline of active tumor volume at a rate of approximately 2.4% per day, resulting in complete remission that persisted until the end of follow-up at 3 years. Thus, the authors conclude that C-11-MET PET may be useful for monitoring chemotherapy in gliomas and deserves further study.PMID: 12889176 [PubMed - indexed for MEDLINE]

M3 - Article

SN - 1552-6569

VL - 13(3)

JO - Journal of Neuroimaging

JF - Journal of Neuroimaging

ER -

Monitoring of the Effect of Chemotherapy in a Mixed Glioma by C-11-methionine PET

Abstract

Fingerprint

Cite this